피리다지논 유도체와 그의 제조방법
    5.
    发明授权
    피리다지논 유도체와 그의 제조방법 失效
    吡咯烷酮衍生物

    公开(公告)号:KR1019930011304B1

    公开(公告)日:1993-11-29

    申请号:KR1019900020229

    申请日:1990-12-10

    Abstract: Ryridazinone derivatives of formula (I) are new. In formula (I), R1= methyl, hydroxymethyl, nitrosylmethyl, monohalomethyl, dihalomethyl or trihalomethyl; X,Y=H, nitro, cyano, -NHCOR3 or - NHSO2R4 (R3,R4= C1-6 alkyl, substituted phenyl or halogen-substd. alkyl); R2=H, C1-6 alkyl, branched alkyl, cyclic alkyl, alkene, alkyne or halogen-substd. alkyl, alkene, alkyne or phenyl-substd. alkyl, alkene, alkyne. Compounds (I) are useful as cardiotonics for enhancing contractile force of cardiac muscle and (I) have antihypertensive activities.

    Abstract translation: 式(I)的哒嗪酮衍生物是新的。 在式(I)中,R 1 =甲基,羟甲基,亚硝基甲基,单卤代甲基,二卤代甲基或三卤代甲基; X,Y = H,硝基,氰基,-NHCOR 3或-NHSO 2 R 4(R 3,R 4 = C 1-6烷基,取代的苯基或卤素取代的烷基); R2 = H,C1-6烷基,支链烷基,环烷基,烯烃,炔烃或卤素取代基。 烷基,烯烃,炔或苯基。 烷基,烯烃,炔烃。 化合物(I)可用作增强心肌收缩力的强心剂,(I)具有抗高血压活性。

Patent Agency Ranking